M. Andrew Wade, SVP and CFO at AtriCure, Inc. (ATRC), sold 2,000 shares at $18.41 ($37K) on 2017-11-30, disclosed to the SEC on 2017-12-01.
Seasonal sale ($37k) by SVP and CFO — this insider has traded ATRC in November in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| ATRC | SELL | 2020-01-16 | $340K | — | Filing → |
| ATRC | SELL | 2019-12-30 | $32K | — | Filing → |
| ATRC | SELL | 2019-11-26 | $351K | — | Filing → |